Trulieve Cannabis (OTCMKTS:TCNNF – Get Free Report) will likely be releasing its results before the market opens on Thursday, February 26th. Analysts expect Trulieve Cannabis to post earnings of ($0.0290) per share and revenue of $297.4650 million for the quarter.
Trulieve Cannabis Stock Down 6.2%
TCNNF opened at $6.10 on Thursday. The business’s 50 day moving average is $7.96 and its two-hundred day moving average is $7.44. Trulieve Cannabis has a 52 week low of $3.02 and a 52 week high of $11.83.
About Trulieve Cannabis
Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.
Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements.
Further Reading
- Five stocks we like better than Trulieve Cannabis
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
